Donor-Derived Fungal Infections in Transplant Patients

Roy, Monika; Park, Benjamin J.; Chiller, Tom

doi:10.1007/s12281-010-0030-x

Cited by 6 publications

(1 citation statement)

References 76 publications

(74 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Infection occurs by inhaling aerosolized microconidia from nitrogen/phosphate-enriched soils contaminated with bird or bat droppings [ 231 ]. There is no person-to-person transmission, but sporadic transmission cases by transplanted organs have been reported [ 232 ]. The primary risk factors include age (<5 years; >55 years), use of medication (chemotherapy medicines, corticosteroids, immunosuppressors, tumor-necrosis-factor inhibitors), and underlying medical conditions (lung diseases, transplanted patients, HIV/AIDS and other secondary immunodeficiencies) [ 231 ].…”

Section: Fungal Infectionsmentioning

confidence: 99%

Clinical Manifestations of Human Exposure to Fungi

Oliveira

Lisboa

et al. 2023

JoF

View full text Add to dashboard Cite

Biological particles, along with inorganic gaseous and particulate pollutants, constitute an ever-present component of the atmosphere and surfaces. Among these particles are fungal species colonizing almost all ecosystems, including the human body. Although inoffensive to most people, fungi can be responsible for several health problems, such as allergic fungal diseases and fungal infections. Worldwide fungal disease incidence is increasing, with new emerging fungal diseases appearing yearly. Reasons for this increase are the expansion of life expectancy, the number of immunocompromised patients (immunosuppressive treatments for transplantation, autoimmune diseases, and immunodeficiency diseases), the number of uncontrolled underlying conditions (e.g., diabetes mellitus), and the misusage of medication (e.g., corticosteroids and broad-spectrum antibiotics). Managing fungal diseases is challenging; only four classes of antifungal drugs are available, resistance to these drugs is increasing, and no vaccines have been approved. The present work reviews the implications of fungal particles in human health from allergic diseases (i.e., allergic bronchopulmonary aspergillosis, severe asthma with fungal sensitization, thunderstorm asthma, allergic fungal rhinosinusitis, and occupational lung diseases) to infections (i.e., superficial, subcutaneous, and systemic infections). Topics such as the etiological agent, risk factors, clinical manifestations, diagnosis, and treatment will be revised to improve the knowledge of this growing health concern.

show abstract

Section: Fungal Infectionsmentioning

confidence: 99%